Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.85p
   
  • Change Today:
    -0.75p
  • 52 Week High: 40.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 1,529,295
  • Market Cap: £26.89m
  • RiskGrade: 479

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
94.76% above the market average94.76% above the market average94.76% above the market average94.76% above the market average94.76% above the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
6.63% below the market average6.63% below the market average6.63% below the market average6.63% below the market average6.63% below the market average
62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average
Price Book Ratio
61.43% below the market average61.43% below the market average61.43% below the market average61.43% below the market average61.43% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
76.61% below the market average76.61% below the market average76.61% below the market average76.61% below the market average76.61% below the market average
53.19% below the sector average53.19% below the sector average53.19% below the sector average53.19% below the sector average53.19% below the sector average
Price Chg 3m
90.12% below the market average90.12% below the market average90.12% below the market average90.12% below the market average90.12% below the market average
78.72% below the sector average78.72% below the sector average78.72% below the sector average78.72% below the sector average78.72% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
47.16% below the market average47.16% below the market average47.16% below the market average47.16% below the market average47.16% below the market average
39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average
Momentum 20
66.96% below the market average66.96% below the market average66.96% below the market average66.96% below the market average66.96% below the market average
53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
1.74% above the market average1.74% above the market average1.74% above the market average1.74% above the market average1.74% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
17.49% below the market average17.49% below the market average17.49% below the market average17.49% below the market average17.49% below the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Forecast EPS
91.56% below the market average91.56% below the market average91.56% below the market average91.56% below the market average91.56% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.27% below the market average35.27% below the market average35.27% below the market average35.27% below the market average35.27% below the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average
Operating Profit Loss
7.12% below the market average7.12% below the market average7.12% below the market average7.12% below the market average7.12% below the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
32.21% below the market average32.21% below the market average32.21% below the market average32.21% below the market average32.21% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Cash
6.25% below the market average6.25% below the market average6.25% below the market average6.25% below the market average6.25% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
25.59% below the market average25.59% below the market average25.59% below the market average25.59% below the market average25.59% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Buys 1y
21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average21.46% above the market average
3.45% below the sector average3.45% below the sector average3.45% below the sector average3.45% below the sector average3.45% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
66.48% above the market average66.48% above the market average66.48% above the market average66.48% above the market average66.48% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 8.85p
Change Today -0.75p
% Change -7.81 %
52 Week High 40.00
52 Week Low 8.00
Volume 1,529,295
Shares Issued 303.83m
Market Cap £26.89m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.66% below the market average28.66% below the market average28.66% below the market average28.66% below the market average28.66% below the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Price Trend
94.48% below the market average94.48% below the market average94.48% below the market average94.48% below the market average94.48% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Income Not Available
Growth
22.40% above the market average22.40% above the market average22.40% above the market average22.40% above the market average22.40% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
16:17 1,535 @ 8.28p
12:23 5,843 @ 8.49p
12:08 6,661 @ 8.49p
12:02 7,063 @ 8.70p
12:02 29,837 @ 8.68p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page